01 20Pfizer Canada Inc.
01 52215923
02 52297163
03 52325045
04 52327285
01 20Gabapentin
01 12Capsule
02 8Tablet
01 52016-04-26
02 52018-08-18
03 102019-05-10
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Brand Name : NEURONTIN
Patent Number : 2297163
Filing Date : 1998-08-18
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Patent Expiration Date : 2016-04-26
Date Granted : 2001-10-09
Brand Name : NEURONTIN
Patent Number : 2215923
Filing Date : 1996-04-26
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-04-26
Date Granted : 2001-10-09
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Brand Name : NEURONTIN
Patent Number : 2297163
Filing Date : 1998-08-18
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Patent Expiration Date : 2016-04-26
Date Granted : 2001-10-09
Brand Name : NEURONTIN
Patent Number : 2215923
Filing Date : 1996-04-26
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-04-26
Date Granted : 2001-10-09
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Brand Name : NEURONTIN
Patent Number : 2297163
Filing Date : 1998-08-18
Strength per Unit : 400mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Brand Name : NEURONTIN
Patent Number : 2297163
Filing Date : 1998-08-18
Strength per Unit : 600mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Brand Name : NEURONTIN
Patent Number : 2297163
Filing Date : 1998-08-18
Strength per Unit : 800mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-08-18
Date Granted : 2001-11-20
Patent Expiration Date : 2019-05-10
Date Granted : 2005-05-03
Brand Name : NEURONTIN
Patent Number : 2325045
Filing Date : 1999-05-10
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-10
Date Granted : 2005-05-03
Patent Expiration Date : 2019-05-10
Date Granted : 2005-06-14
Brand Name : NEURONTIN
Patent Number : 2327285
Filing Date : 1999-05-10
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-10
Date Granted : 2005-06-14
Patent Expiration Date : 2019-05-10
Date Granted : 2005-05-03
Brand Name : NEURONTIN
Patent Number : 2325045
Filing Date : 1999-05-10
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-10
Date Granted : 2005-05-03
